<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2019-34-1-107-117</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-688</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>АТЕРОСКЛЕРОТИЧЕСКОЕ ПОРАЖЕНИЕ БРАХИОЦЕФАЛЬНЫХ АРТЕРИЙ ПРИ РЕВМАТОИДНОМ АРТРИТЕ И ЕГО АССОЦИАЦИЯ С ФАКТОРАМИ СЕРДЕЧНО-СОСУДИСТОГО РИСКА</article-title><trans-title-group xml:lang="en"><trans-title>ATHEROSCLEROTIC LESION OF CAROTID ARTERIES IN RHEUMATOID ARTHRITIS AND ITS ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омельченко</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Omelchenko</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-ревматолог, врач-терапевт, младший научный сотрудник лаборатории патологии соединительной ткани, </p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>M.D., Rheumatologist, Therapeutist, Research Fellow at the Laboratory of Connective Tissue Disease,</p><p>2, Timakova str., Novosibirsk, 630117</p></bio><email xlink:type="simple">v.o.omelchenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Летягина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Letyagina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, врач-ревматолог, врач-терапевт, заведующая ревматологическим отделением клиники, старший научный сотрудник лаборатории патологии соединительной ткани,</p><p> </p></bio><bio xml:lang="en"><p>M.D., Cand. Sci. (Med.), Rheumatologist, Therapeutist, Head of the Rheumatology Department of the RICEL Clinic; Senior Researcher at the Laboratory of Connective Tissue Disease,</p><p>2, Timakova str., Novosibirsk, 630117</p></bio><email xlink:type="simple">elena_letyagina@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Korolev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, заведующий лабораторией патологии соединительной ткани,</p><p> </p></bio><bio xml:lang="en"><p>M.D., Cand. Sci. (Med.), Rheumatologist, Head of the Laboratory of Connective Tissue Disease,</p><p>2, Timakova str., Novosibirsk, 630117</p></bio><email xlink:type="simple">kormax@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поспелова</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pospelova</surname><given-names>T. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующая кафедрой терапии, гематологии и трансфузиологии, 630091, Новосибирск, Красный пр., 52;</p><p>врач-гематолог, руководитель Городского гематологического центра</p></bio><bio xml:lang="en"><p>M.D., Dr. Sci. (Med.), Professor, Hematologist, Head of the Department of Therapy, Hematology and Transfusiology,</p><p>52, Krasny prosp., Novosibirsk, 630091</p></bio><email xlink:type="simple">post_gem@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт клинической и экспериментальной лимфологии — филиал Института цитологии и генетики Сибирского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Clinical and Experimental Lymphology — Branch of Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Новосибирский государственный медицинский университет Министерства здравоохранения Российской Федерации;&#13;
Городской гематологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>22</day><month>04</month><year>2019</year></pub-date><volume>34</volume><issue>1</issue><fpage>107</fpage><lpage>117</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Омельченко В.О., Летягина Е.А., Королев М.А., Поспелова Т.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Омельченко В.О., Летягина Е.А., Королев М.А., Поспелова Т.И.</copyright-holder><copyright-holder xml:lang="en">Omelchenko V.O., Letyagina E.A., Korolev M.A., Pospelova T.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/688">https://www.sibjcem.ru/jour/article/view/688</self-uri><abstract><sec><title>Введение</title><p>Введение. Больные ревматоидным артритом (РА) чаще демонстрируют развитие сердечно-сосудистых катастроф. Имеющиеся рискометры разработаны для общей популяции и недостаточно адекватно оценивают вероятность наступления сердечно-сосудистых событий. Изучение факторов риска у больных РА необходимо для своевременной диагностики и профилактики.</p></sec><sec><title>Цель исследования</title><p>Цель исследования: проанализировать частоту встречаемости атеросклеротического поражения брахиоцефальных артерий у больных РА и его ассоциацию с факторами сердечно-сосудистого риска (ССР).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 212 больных РА, средний возраст составил 58,0 года [48,3; 65,0], преимущественно с умеренной и высокой активностью заболевания (DAS28 4,96 [3,86; 5,85]). Соотношение женщин и мужчин составило 5,8 к 1. В процессе исследования выполняли общеклиническое обследование больных, выявление традиционных факторов ССР, определение активности заболевания. Поражение брахиоцефальных артерий определяли при помощи ультразвуковой допплерографии с выявлением атеросклеротических бляшек (АСБ) и измерением толщины комплекса интима-медиа (КИМ).</p></sec><sec><title>Результаты</title><p>Результаты. АСБ встречались у 59 больных (27,8%), преимущественно у мужчин (51,6 против 23,8% у женщин, р=0,001) и в более старшем возрасте (66,0 [59,0; 73,0] против 55,0 года [42,0; 61,0], р&lt;0,001). У курящих больных АСБ выявлялись в 46,3% случаев против 23,4% в оппозитной группе (р=0,003). АСБ чаще обнаруживались у больных сахарным диабетом 2-го типа (58,3 против 26,0%, р=0,036), артериальной гипертонией (41,7 против 5,0%, р&lt;0,001), стенокардией напряжения (73,1 против 21,5%, р&lt;0,001), острым нарушением мозгового кровообращения в анамнезе (83,3 против 25,9%, р=0,008) и c наличием постинфарктного кардиосклероза (100,0 против 26,6%, р=0,03). Ни у одной из 48 женщин, не вступивших в менопаузу, АСБ не обнаруживались. За исключением уровня ревматоидного фактора, другие показатели активности РА не продемонстрировали значимых различий между группами с АСБ и без таковых. Толщина КИМ в основном зависела от возраста (rs=0,633, p&lt;0,001) и не была связана с активностью заболевания. При использовании половозрастных норм доля больных с утолщением КИМ возросла с 34,9 до 58,0% (p&lt;0,001). Распространенность большинства факторов ССР была ассоциирована с возрастом и полом.</p></sec><sec><title>Заключение</title><p>Заключение. Проведенное исследование выявило отличия в распространенности традиционных факторов риска у больных РА по сравнению с мировыми исследованиями и сопоставимые результаты с исследованием РЕМАРКА, что подтверждает важность изучения этого вопроса на примере российской популяции. Полученные в данном исследовании результаты улучшают понимание структуры факторов риска у больных РА и могут лечь в основу алгоритма курации больных с высоким ССР.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Cardiovascular complications are more often observed in patients with rheumatoid arthritis. Available cardiovascular risk scales were developed for general population and provide in sufficiently adequate assessment of the cardiovascular event likelihood. Studying the risk factors in rheumatoid arthritis patients is necessary for timely diagnosis and prevention.</p></sec><sec><title>Objective</title><p>Objective: To analyze the incidence of atherosclerotic lesions in the brachiocephalic arteries in patients with rheumatoid arthritis and associations of this pathology with cardiovascular risk factors.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. Two hundred and twelve Caucasian patients with rheumatoid arthritis (age of 58.0 years [48.3; 65.0]; Disease Activity Score-28 of 4.96 [3.86; 5.85]) were included in our study. Patients had American College of Rheumatology-defined rheumatoid arthritis (1987 classification criteria). The ratio of women to men was 5.8 to 1. General clinical examination of patients, the identification of traditional cardiovascular risk factors, and the determination of disease activity were performed. The atherosclerotic progression was assessed by ultrasonography with carotid intima-media thickness measurement and atherosclerotic plaque detection. All patients gave written informed consent before enrollment into the study.</p></sec><sec><title>Results</title><p>Results. Atherosclerotic plaques were found in 59 patients (27.8%), predominantly in older individuals (66.0 [59.0; 73.0] versus 55.0 years [42.0; 61.0], p&lt;0.001) and in men (51.6 versus 23.8% in women, p=0.001). Atherosclerotic plaques were detected in 46.3% of smokers versus 23.4% of non-smokers (p=0.003). Atherosclerotic plaques were more frequently detected in patients with type 2 diabetes mellitus (58.3 versus 26.0%, p=0.036), arterial hypertension (41.7 versus 5.0%, p&lt;0.001), angina pectoris (73.1 versus 21.5%, p&lt;0.001), past history of acute cerebrovascular event (83.3 versus 25.9%, p=0.008), and the presence of post-infarction cardiosclerosis (100.0 versus 26.6%, p=0.03). No atherosclerotic plaques were found in 48 non-climacteric women. Except for the level of rheumatoid factor, all parameters of rheumatoid arthritis activity did not demonstrate statistically significant differences between groups with and without atherosclerotic plaques. The intima-media thickness mainly correlated with age (rs=0.633, p&lt;0.001) and was not associated with rheumatoid arthritis activity. After the use of age- and sex-specific ultrasound criteria, the proportion of patients with intima-media thickening increased from 34.9 to 58.0% (p&lt;0.001). Prevalence rates of most cardiovascular risk factors were associated with age and gender.</p></sec><sec><title>Conclusion</title><p>Conclusion. The present study identified the differences between the incidence rates of traditional risk factors in patients with rheumatoid arthritis compared with the corresponding values in world studies and generated comparable results with REMARKA study confirming a significance of studying this question in the context of the Russian population. The results, obtained in this study, improve understanding of the structure of risk factors in patients with rheumatoid arthritis and may provide the basis for the algorithm of curation of patient with high cardiovascular risk.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>атеросклероз</kwd><kwd>факторы риска</kwd><kwd>комплекс интима-медиа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>atherosclerosis</kwd><kwd>risk factors</kwd><kwd>intima-media thickness</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cobb S., Anderson F., Bauer W. Length of Life and Cause of Death in Rheumatoid Arthritis. N. Engl. J. Med. 1953;249(14):553–556. http://www.nejm.org/doi/abs/10.1056/NEJM195310012491402.</mixed-citation><mixed-citation xml:lang="en">Cobb S., Anderson F., Bauer W. Length of Life and Cause of Death in Rheumatoid Arthritis. N. Engl. J. Med. 1953;249(14):553–556. http://www.nejm.org/doi/abs/10.1056/NEJM195310012491402.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Libby P. History of Discovery: Inflammation in Atherosclerosis. Arter. Thromb. Vasc. Biol. 2012;32(9):2045–2051.</mixed-citation><mixed-citation xml:lang="en">Libby P. History of Discovery: Inflammation in Atherosclerosis. Arter. Thromb. Vasc. Biol. 2012;32(9):2045–2051.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Crowson C.S., Rollefstad S., Ikdahl E., Kitas G.D., van Riel P.L.C.M., Gabriel S.E., et al; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2018;77(1):48–54.</mixed-citation><mixed-citation xml:lang="en">Crowson C.S., Rollefstad S., Ikdahl E., Kitas G.D., van Riel P.L.C.M., Gabriel S.E., et al. A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2018;77(1): 48–54.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Amaya-Amaya J., Sarmiento-Monroy J.C., Mantilla R.-D., Pineda-TamayoR., Rojas-Villarraga A., Anaya J.-M. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol. Res. 2013;56(2–3):267–286. Available from: http://link.springer.com/10.1007/s12026-013-8398-7.</mixed-citation><mixed-citation xml:lang="en">Amaya-Amaya J., Sarmiento-Monroy J.C., Mantilla R.-D., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J.-M. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol. Res. 2013;56(2–3):267–286. Available from: http://link.springer.com/10.1007/s12026-013-8398-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Малютина С.К., Рябиков А.Н., Палехина Ю.Ю., Шахматов С.Г., Рябиков М.Н., Гусева В.П. Поло- и возрастоспецифические референсные критерии толщины интимы-медии сонных артерий в типичной российской популяции. Ультразвуковая и функциональная диагностика. 2015;(55):107b.</mixed-citation><mixed-citation xml:lang="en">Malyutina S.K., Ryabikov A.N., Palekhina Y.Y., Shakhmatov S.G., Ryabikov M.N., Guseva V.P. Sex- and age-specific reference criteria for the intima-media thickness of carotid arteries in a typical Russian population. Ultrasond Funct. Diagnostics. 2015;(55):107b (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Taverner D., Vallvé J.-C., Ferré R., Paredes S., Masana L., Castro A. Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age. PLoS One. 2018;13(3):e0193690. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29494666.</mixed-citation><mixed-citation xml:lang="en">Taverner D., Vallvé J.-C., Ferré R., Paredes S., Masana L., Castro A. Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age. PLoS One. 2018;13(3):e0193690. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29494666.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Berry J.D., Lloyd-Jones D.M., Garside D.B., Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. Am. Heart J. 2007;154(1):80–86.</mixed-citation><mixed-citation xml:lang="en">Berry J.D., Lloyd-Jones D.M., Garside D.B., Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. Am. Heart J. 2007;154(1):80–86.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Воевода М.И., Ковалькова Н.А., Рагино Ю.И., Травникова Н.Ю., Денисова Д.В. Распространенность компонентов метаболического синдрома у молодых лиц. Атеросклероз. 2015;11(4):56–61.</mixed-citation><mixed-citation xml:lang="en">Voevoda M.I., Kovalkova N.A., RaginoYu.I., TravnikovaN.Yu., Denisova D.V. Prevalence of metabolic syndrome components in young individuals. Atherosclerosis. 2015;11(4):56–61 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Giles J.T., Allison M., Blumenthal R.S., Post W., Gelber A.C., Petri M., et al. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum. 2010, Nov;62(11):3173–3182. Available from http://doi.wiley.com/10.1002/art.27629.</mixed-citation><mixed-citation xml:lang="en">Giles J.T., Allison M., Blumenthal R.S., Post W., Gelber A.C., Petri M., et al. Abdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum. 2010 Nov;62(11):3173–3182. Available from: http://doi.wiley.com/10.1002/art.27629.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Удачкина Е.В., Новикова Д.С., Попкова Т.В., Кириллова И.Г., Маркелова Е.И., Горбунова Ю.Н. и др. Прогрессирование атеросклероза сонных артерий у больных ранним ревматоидным артритом на фоне противоревматической терапии, проводимой по принципу «Лечение до достижения цели». Научно-практическая ревматология. 2018;56(4):449 455. https://doi.org/10.14412/1995-4484-2018-449-455.</mixed-citation><mixed-citation xml:lang="en">Udachkina E.V., Novikova D.S., Popkova T.V., Kirillova I.G., Markelova E.I., Gorbunova Y.N., et al. Progression of carotid artery atherosclerosis during treatment to target in patients with early rheumatoid arthritis. Rheumatology Science and Practice. 2018;56(4): 449 455. https://doi.org/10.14412/1995-4484-2018-449-455 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Weijers J.M., Rongen-van Dartel S.A.A., Hoevenaars D.M.G.M.F., Rubens M., Hulscher M.E.J.L., van Riel P.L.C.M. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: Results of a successful collaboration between primary and second arycare. Ann. Rheum. Dis. 2018, Apr;77(4):480– 483. Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2017-212392.</mixed-citation><mixed-citation xml:lang="en">Weijers J.M., Rongen-van Dartel S.A.A., Hoevenaars D.M.G.M.F., Rubens M., Hulscher M.E.J.L., van Riel P.L.C.M. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care. Ann. Rheum. Dis. 2018 Apr;77(4):480– 483. Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2017-212392.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ruscitti P., Margiotta D.P.E., Macaluso F., Iacono D., D’Onofrio F., Emmi G., et al. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis. Medicine (Baltimore). 2017;96(42):e8180. Available from: http://insights.ovid.com/crossref?an=00005792-201710200-00038.</mixed-citation><mixed-citation xml:lang="en">Ruscitti P., Margiotta D.P.E., Macaluso F., Iacono D., D’Onofrio F., Emmi G., et al. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis. Medicine (Baltimore). 2017;96(42):e8180. Available from: http://insights.ovid.com/crossref?an=00005792-201710200-00038.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ambrosino P., Lupoli R., di Minno A., Tasso M., Peluso R., di Minno M.N. D. Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies. Thrombosis and Haemostasis. 2015;113:916–930.</mixed-citation><mixed-citation xml:lang="en">Ambrosino P., Lupoli R., di Minno A., Tasso M., Peluso R., di Minno M.N.D. Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies. Thrombosis and Haemostasis. 2015;113:916–930.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J. Rheumatol. 2005;32(7):1219–1223.</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J. Rheumatol. 2005;32(7):1219–1223.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Primdahl J., Clausen J., Hørslev-Petersen K. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann. Rheum. Dis. 2013;72(11):1771–1776. Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2013-203682.</mixed-citation><mixed-citation xml:lang="en">Primdahl J., Clausen J., Hørslev-Petersen K. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann. Rheum. Dis. 2013;72(11):1771–1776. http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2013-203682.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
